Glenmark Pharmaceuticals has informed about a Press Release dated July 20, 2016, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Rosuvastatin Calcium Tablets, 5 mg (base), 10 mg (base), 20 mg (base), and 40 mg (base)’.
The above information is a part of company’s filings submitted to BSE.